Señales en vivo de 688278.SS | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 may 2024 @ 03:00):

Xiamen Amoytop Biotech Co., Ltd. engages in the manufacture, marketing, and sale of recombinant protein drugs using genetic engineering technology in China...

Stats
Volumen de hoy	3.33M
Volumen promedio	2.47M
Capitalización de mercado	23.90B
EPS	CNY0.320 ( 2024-04-29 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	39.70
ATR14	CNY0.0630 (0.11%)

Volumen Correlación

Largo: 0.06 (neutral)

Corto: 0.54 (weak)

Signal:(47.981) Neutral

Xiamen Amoytop Biotech Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Xiamen Amoytop Biotech Correlación - Moneda/Commodity

0.29
( neutral )

-0.41
( neutral )

0.00
( neutral )

-0.75
( moderate negative )

0.61
( weak )

-0.32
( neutral )

Xiamen Amoytop Biotech Finanzas

Annual	2023
Ingresos:	CNY2.10B
Beneficio Bruto:	CNY1.96B (93.33 %)
EPS:	CNY1.370

FY	2023
Ingresos:	CNY2.10B
Beneficio Bruto:	CNY1.96B (93.33 %)
EPS:	CNY1.370

FY	2022
Ingresos:	CNY1.53B
Beneficio Bruto:	CNY1.36B (88.92 %)
EPS:	CNY0.710

FY	2021
Ingresos:	CNY1.13B
Beneficio Bruto:	CNY1.01B (88.95 %)
EPS:	CNY0.450

Financial Reports:

No articles found.

Xiamen Amoytop Biotech

Xiamen Amoytop Biotech Co., Ltd. engages in the manufacture, marketing, and sale of recombinant protein drugs using genetic engineering technology in China. It offers formulations, reagents, and APIs, as well as custom-manufacturing services. The company was founded in 1996 and is based in Xiamen, China.